What is alpha lipoic acid?
alpha lipoic acid often known as ALA, is a sulfur-containing molecule that is produced in human cells in trace quantities by spontaneous synthesis. As a cofactor, it is required by the mitochondrial enzyme complexes that are involved in the process of energy metabolism, particularly those that are involved in the routes of oxidative decarboxylation.
When alpha-lipoic acid is administered in the context of industrial settings, it is often in the form of a crystalline powder that has been purified. The chemical formula that identifies this material, which is a solid that ranges in colour from light yellow to yellow, is CAS No. 1077-28-7. The molecular formula for this substance is C₈H₁₄O₂S₂.
The fact that ALA is partially soluble in both aqueous and lipid environments makes it feasible for it to interact with a wide variety of cellular compartments. This is in contrast to the majority of antioxidants, which are able to operate in either of these environments separately.
When viewed from a biochemical perspective, ALA and its reduced form, which is referred to as dihydrolipoic acid, are involved in redox reactions that have an impact on the oxidative equilibrium that takes place inside cells.
Key properties include:
· Dual solubility in lipid and aqueous phases
· Reversible redox cycling (oxidized ↔ reduced form)
· Participation in mitochondrial enzyme systems
· Interaction with other antioxidant molecules (e.g., glutathione, vitamin C)
It is because of these features that ALA is extensively investigated in the context of studies pertaining to oxidative stress and metabolic processes.
Product Name:alpha lipoic acid
CAS No.:1077-28-7
Specification:99%
Test Method:HPLC
Appearance:Light yellow to yellow powder
Shelf Life: 2 years
Minimum Order Quantity: 1 kg
Samples: Free samples available
Certifications: GMP, ISO, HACCP, KOSHER, and HALAL.
Payment: Various payment methods accepted.
Advantages: Manufactured in a 100,000-grade cleanroom, our products are additive-free, non-GMO
Inner Package: Double PE Bags; Net 5kg/Bag
Outside Package: Paper Drums, Net 25kg/Drum
Storage:Store in a cool, dry place away from Light and Heat.

Production Forms and Industrial Classification
Powder, Enantiomers, and Manufacturing Routes
Forms of alpha-lipoic acid
Additionally, alpha-lipoic acid powder is often supplied in a number of different forms throughout commercial supply chains.
· Crystalline powder (most common bulk form)
· Enriched R-enantiomer (higher bioactivity in some studies)
· Racemic mixture (R/S combination, widely used in industry)
Because of its versatility in terms of mixing, encapsulating, and liquid formulation, powder form is often the kind of formulation that is favoured for downstream applications.
Manufacturing pathways
Alpha-lipoic acid can be produced through different methods:
· Chemical synthesis: widely used for large-scale production
· Biotechnological fermentation: used for certain “natural-source” positioning
When properly managed, both processes are capable of producing high-purity material; nevertheless, depending on the jurisdiction, there may be disparities in the cost structure, stereochemistry distribution, and regulatory posture of the two approaches.
Quality and specification considerations
Industrial-grade alpha-lipoic acid is typically evaluated based on:
· Purity (commonly ≥98–99% depending on grade)
· Residual solvent levels
· Heavy metal limits
· Microbial contamination control
· Stability under storage conditions
Analysis techniques such as high-performance liquid chromatography (HPLC) and spectroscopy are often used to validate these properties.

Functional Properties and Application Context
Antioxidant behavior and biological relevance
Dual-phase antioxidant activity
One of the qualities of alpha-lipoic acid that has been researched the most often is its capacity to function in both aqueous and lipid environments. This is one of the properties that has been investigated the most. It is distinguishable from a large number of conventional antioxidants, which fall into the category of compartment-limited antioxidants, by virtue of this.
In research contexts, ALA is described as:
· A direct scavenger of reactive oxygen species (ROS)
· A compound capable of recycling other antioxidants in reduced form
· A modulator of redox signaling pathways
The magnitude of these effects, on the other hand, is contingent upon the dose, the bioavailability, and the biological environment.
Interaction with other antioxidants
ALA is often studied in combination with other antioxidant systems such as:
· Glutathione metabolism pathways
· Vitamin C regeneration cycles
· Vitamin E lipid-phase protection
In the field of biochemistry, these interactions are sometimes referred to as "network antioxidant effects," although the extent to which they are therapeutically important varies substantially from one research to the next.
Application domains
Alpha-lipoic acid powder is used across several industries:
· Nutritional supplements (metabolic support formulations)
· Pharmaceutical research (oxidative stress studies)
· Cosmetic formulations (antioxidant ingredient systems)
· Functional food development
The incorporation of this ingredient is often motivated by formulation design objectives rather than by effectiveness claims made independently.

Rebecca Alpha-Lipoic Acid Powder Supplier
In order to meet your requirements for alpha-lipoic acid powder procurement, Rebecca is prepared to provide you with pharmaceutical-grade ingredients that are supported by stringent quality assurance and industry-leading technical competence. Our alpha-lipoic acid powder (CAS 1077-28-7) is 99% pure, and it is provided as a light yellow to yellow crystalline substance. It has been confirmed by HPLC methods, and it satisfies the stringent requirements of research and development applications in the pharmaceutical industry, with nutraceutical formulation, and cosmetic development industries. We are able to guarantee supply dependability that is comparable to the size of global distribution networks thanks to our yearly production capacity that exceeds 500 metric tonnes and our three specialised manufacturing lines. Our GMP and ISO-certified facilities in Shaanxi, China use cutting-edge extraction and purification technologies to guarantee outstanding batch consistency and full compliance documentation. These technologies include certificates of analysis, heavy metal testing, and microbiological analysis. Our experienced staff provides timely communication and adaptable solutions, regardless of whether you want bulk quantities with competitive FOB/CIF/DDP prices or whether you require customised requirements to assist product innovation. In order to seek samples, technical requirements, or personalised prices from a reliable alpha-lipoic acid powder manufacturer who is devoted to your success, please contact our procurement experts at information@sxrebecca.com.

FAQ
Is Alpha-Lipoic Acid Powder More Effective Than Capsules?
The effectiveness comparison depends on application context rather than inherent superiority. Raw powder offers formulation flexibility enabling custom delivery systems—sustained-release matrices, liposomal encapsulation, or beverage integration—potentially enhancing bioavailability beyond standard capsules. Capsules provide convenience and precise pre-measured dosing but introduce excipient variables affecting dissolution profiles. Pharmaceutical developers choose powder for maximum formulation control, while brands prioritizing manufacturing simplicity may prefer finished capsule procurement.
Can Alpha-Lipoic Acid Be Safely Used in Cosmetic Formulations?
ALA demonstrates excellent safety profiles in dermal applications when formulated within appropriate concentration ranges (typically 0.5-5%) and pH parameters (5.0-7.0). Comprehensive safety assessments including dermal irritation studies, sensitization testing, and stability evaluations support cosmetic use. Procurement specifications should verify low-irritation profiles through supplier-provided HRIPT data. The compound's antioxidant properties and small molecular structure enable beneficial skin interactions, though formulation expertise ensures optimal stability and consumer experience.
How Do I Verify Pharmaceutical-Grade Quality?
Certification of pharmaceutical-grade quality requires many layers of verification. Test results from accredited laboratories showing 99% or higher purity by high-performance liquid chromatography (HPLC), with residual solvent levels below ICH limits, heavy metal levels below USP parameters, and microbiological contamination within compendial standards; and this information must be presented in an analytical certificate. Good Manufacturing Practice (GMP) certification from production facilities, DMF file numbers for regulatory filings, and stability data under specified storage conditions all contribute to an additional layer of quality assurance. After receiving the item, it is subjected to independent third-party testing to ensure its ultimate authenticity. The obtained material is compared to the stated specifications by recognised analytical laboratories in this testing.
References
1. Shay, K.P., Moreau, R.F., Smith, E.J., Smith, A.R., & Hagen, T.M. (2009). Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochimica et Biophysica Acta, 1790(10), 1149-1160.
2. Goraca, A., Huk-Kolega, H., Piechota, A., Kleniewska, P., Ciejka, E., & Skibska, B. (2011). Lipoic acid - biological activity and therapeutic potential. Pharmacological Reports, 63(4), 849-858.
3. Packer, L., Witt, E.H., & Tritschler, H.J. (1995). Alpha-lipoic acid as a biological antioxidant. Free Radical Biology and Medicine, 19(2), 227-250.
4. Golbidi, S., Badran, M., & Laher, I. (2011). Diabetes and alpha lipoic acid. Frontiers in Pharmacology, 2, 69.
5. Kagan, V.E., Shvedova, A., Serbinova, E., Khan, S., Swanson, C., Powell, R., & Packer, L. (1992). Dihydrolipoic acid - a universal antioxidant both in the membrane and in the aqueous phase. Biochemical Pharmacology, 44(8), 1637-1649.
6. Biewenga, G.P., Haenen, G.R., & Bast, A. (1997). The pharmacology of the antioxidant lipoic acid. General Pharmacology, 29(3), 315-331.








